Managers / Q4 2025 · view latest →
Q3 Asset Management
CIK 0001732543 · 2175 COLE, BIRMINGHAM, MI, 48009 · 2485661122
Summary
Q3 Asset Management reported $437M in U.S.-listed holdings across 62 positions for Q4 2025.
The portfolio is heavily concentrated: XHLF alone accounts for 55.2% of reported value.
Compared with Q3 2025, the fund opened 32 new positions and exited 25.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ETP · 94.2% · $412M
- Common Stock · 5.8% · $25M
Quarter-over-Quarter Changes full breakdown →
vs Q3 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| Q3 ALL SEASON TACTICAL ADVANTAGE ETF | NEW | +519.9K | 519.9K | +$13M | $13M |
| OIHVANECK VECTORS OIL SERVICES ETF | NEW | +35.9K | 35.9K | +$10M | $10M |
| DIASPDR DOW JONES INDL AVERAGE ETF TR UNIT SER 1 | NEW | +20.9K | 20.9K | +$10M | $10M |
| FHLCFidelity MSCI Health Care Index ETF | NEW | +84.9K | 84.9K | +$6M | $6M |
| XBISPDR S&P Biotech ETF USD Class | NEW | +47.2K | 47.2K | +$6M | $6M |
| INTCINTEL CORP | NEW | +118.6K | 118.6K | +$4M | $4M |
| IBBISHARES BIOTECHNOLOGY ETF | NEW | +23.7K | 23.7K | +$4M | $4M |
| XLVSELECT SECTOR SPDR FD HEALTH CARE | NEW | +24.6K | 24.6K | +$4M | $4M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2025
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $412M | 64 | Apr 28, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $437M | 62 | Jan 27, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $292M | 55 | Oct 27, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $146M | 56 | May 1, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $161M | 47 | Jan 24, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $427M | 45 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $441M | 48 | Jul 30, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $352M | 46 | Apr 25, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $396M | 46 | Jan 29, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $252M | 45 | Nov 3, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $206M | 43 | Jul 28, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $120M | 43 | Apr 26, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $148M | 45 | Feb 2, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $137M | 43 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $132M | 38 | Aug 2, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $217M | 40 | May 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $235M | 41 | Jan 25, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $207M | 44 | Oct 29, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $204M | 40 | Jul 26, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $188M | 47 | May 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $126M | 39 | Feb 9, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $123M | 27 | Oct 22, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $105M | 26 | Jul 24, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $97M | 27 | May 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $44M | 31 | Jan 27, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $40M | 26 | Oct 24, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $43M | 33 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $37M | 25 | Apr 17, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $40M | 16 | Feb 4, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.